Abstract
Research has confirmed the effectiveness of medications, when used in conjunction with ongoing counseling, to treat substance abuse disorders. This article describes a national, mixed-methods research project designed to investigate single state authorities' (SSAs) perceptions of adoption of evidence-based practices in substance abuse treatment. Results are focused specifically on medication-assisted treatment, one of five evidence-based practices defined by the National Quality Forum. Medication-assisted treatment (MAT) is an important and effective part of comprehensive care options available to clients who are chronically ill with alcohol and other drug disorders. Despite mounting clinical evidence and increased availability, overall rates of implementation and sustained adoption of medications to treat addiction remain limited. The results illustrate that the SSA representatives who fund public treatment programs believe MAT is a priority and worthy of system-wide implementation. Current strategies utilized by SSAs to support the adoption of MAT are detailed, as are barriers to adoption and implementation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 227-238 |
| Number of pages | 12 |
| Journal | Journal of Psychoactive Drugs |
| Volume | Suppl 6 |
| State | Published - Sep 2010 |
Fingerprint
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Psychology(all)
Cite this
Adoption of medications in substance abuse treatment : priorities and strategies of single state authorities. / Rieckmann, Traci; Kovas, Anne E.; Rutkowski, Beth A.
In: Journal of Psychoactive Drugs, Vol. Suppl 6, 09.2010, p. 227-238.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Adoption of medications in substance abuse treatment
T2 - priorities and strategies of single state authorities.
AU - Rieckmann, Traci
AU - Kovas, Anne E.
AU - Rutkowski, Beth A.
PY - 2010/9
Y1 - 2010/9
N2 - Research has confirmed the effectiveness of medications, when used in conjunction with ongoing counseling, to treat substance abuse disorders. This article describes a national, mixed-methods research project designed to investigate single state authorities' (SSAs) perceptions of adoption of evidence-based practices in substance abuse treatment. Results are focused specifically on medication-assisted treatment, one of five evidence-based practices defined by the National Quality Forum. Medication-assisted treatment (MAT) is an important and effective part of comprehensive care options available to clients who are chronically ill with alcohol and other drug disorders. Despite mounting clinical evidence and increased availability, overall rates of implementation and sustained adoption of medications to treat addiction remain limited. The results illustrate that the SSA representatives who fund public treatment programs believe MAT is a priority and worthy of system-wide implementation. Current strategies utilized by SSAs to support the adoption of MAT are detailed, as are barriers to adoption and implementation.
AB - Research has confirmed the effectiveness of medications, when used in conjunction with ongoing counseling, to treat substance abuse disorders. This article describes a national, mixed-methods research project designed to investigate single state authorities' (SSAs) perceptions of adoption of evidence-based practices in substance abuse treatment. Results are focused specifically on medication-assisted treatment, one of five evidence-based practices defined by the National Quality Forum. Medication-assisted treatment (MAT) is an important and effective part of comprehensive care options available to clients who are chronically ill with alcohol and other drug disorders. Despite mounting clinical evidence and increased availability, overall rates of implementation and sustained adoption of medications to treat addiction remain limited. The results illustrate that the SSA representatives who fund public treatment programs believe MAT is a priority and worthy of system-wide implementation. Current strategies utilized by SSAs to support the adoption of MAT are detailed, as are barriers to adoption and implementation.
UR - http://www.scopus.com/inward/record.url?scp=79952111434&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952111434&partnerID=8YFLogxK
M3 - Article
C2 - 21138199
AN - SCOPUS:79952111434
VL - Suppl 6
SP - 227
EP - 238
JO - Journal of Psychoactive Drugs
JF - Journal of Psychoactive Drugs
SN - 0279-1072
ER -